Novel therapeutic targets for appetite regulation

Current Opinion in Investigational Drugs

Volumn 6, Issue 4, 2005, Pages 369-372

  Small, Caroline J ^a   Parkinson, James R ^a   Bloom, Stephen R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Appetite; Gut hormones; Obesity; Peptide YY

Indexed keywords

AGOUTI RELATED PROTEIN; ANOREXIGENIC AGENT; ANTIDIABETIC AGENT; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; DIPEPTIDYL PEPTIDASE IV; EXENDIN 4; G PROTEIN COUPLED RECEPTOR; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GROWTH HORMONE SECRETAGOGUE RECEPTOR; INCRETIN; INSULIN; NEUROPEPTIDE Y; OXYNTOMODULIN; PEPTIDE YY; PLACEBO; PROOPIOMELANOCORTIN; PROTEIN C FOS; SIBUTRAMINE; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG;

ALPHA TOCOPHEROL DEFICIENCY; APPETITE; ARCUATE NUCLEUS; BARIATRIC SURGERY; BINDING AFFINITY; BYPASS SURGERY; CELL FUNCTION; CELL POPULATION; CLINICAL TRIAL; CORRELATION FUNCTION; DRUG RECEPTOR BINDING; EATING HABIT; EX VIVO STUDY; FOOD INTAKE; GROWTH HORMONE RELEASE; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPERPHAGIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RELEASE; L CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVERNUTRITION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RETINOL DEFICIENCY; REVIEW; SATIETY; SIDE EFFECT; SIGNAL TRANSDUCTION; TACHYCARDIA; THALAMUS MIDLINE NUCLEUS; WEIGHT GAIN; WEIGHT REDUCTION;

APPETITE REGULATION; DRUG DELIVERY SYSTEMS; HUMANS; OBESITY;

EID: 17644390599     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Bourn J: Tackling obesity in England. National Audit Office, London, UK (2001) HC 220:1-72.
2. Bi S, Moran TH: Actions of CCK in the controls of food intake and body weight: Lessons from the CCK-A receptor deficient OLETF rat. Neuropeptides (2002) 36(2-3):171-181.
3. Dhillo WS, Bloom SR: Gastrointestinal hormones and regulation of food intake. Horm Metab Res (2004) 36 11-12):846-851.
4. Klaus S: Adipose tissue as a regulator of energy balance. Curr Drug Targets (2004) 5(3):241-250.
5. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG: Central nervous system control of food intake. Nature (2000) 404(6778):661-671.
6. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS: Interacting appetite-regulating pathways in the hypothalamic regulation of bodyweight. Endocr Rev (1999) 20(1):68-100.
7. Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, Low MJ: The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord (2001) 25(Suppl 5):S63-S67.
8. Cowley MA, Cone RD, Enriori P, Louiselle I, Williams SM, Evans AE: Electrophysiological actions of peripheral hormones on melanocortin neurons. Ann NY Acad Sci (2003) 994:175-186.
9. Barsh GS, Farooqi IS, O'Rahilly S: Genetics of body-weight regulation. Nature (2000) 404(6778):644-651.
10. O'Rahilly S: Life without leptin. Nature (1998) 392(6674):330-331.
11. Strader AD, Woods SC: Gastrointestinal hormones and food intake. Gastroenterology (2005) 128(1):175-191.
12. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR: Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology (1985) 89 5):1070-1077.
13. Ekblad E, Sundler F: Distribution of pancreatic polypeptide and peptide YY. Peptides (2002) 23(2):251-261.
14. Larhammar D: Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept (1996) 65(3):165-174.
15. Eberlein GA, Eysselein VE, Schaeffer M, Layer P, Grandt D, Goebell H, Niebel W, Davis M, Lee TD, Shively JE et al: A new molecular form of PYY: Structural characterisation of human PYY(3-36) and PYY(1-36). Peptides (1989) 10(4):797-803.
16. Grandt D, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE, Reeve JR Jr: Two molecular forms of peptide YY (PYY) are abundant in human blood: Characterisation of a radioimmunoassay recognising PYY1-36 and PYY3-36. Regul Pept (1994) 51 2):151-159.
17. Fujimiya M, Inui A: Peptidergic regulation of gastrointestinal motility in rodents. Peptides (2000) 21 10):1565-1582.
18. Hoentjen F, Hopman WP, Jansen JB: Effect of circulating peptide YY on gall bladder emptying in humans. Scand J Gastroenterol (2001) 36(10):1086-1091.
19. Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR: Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut (1987) 28(2):166-170.
20. Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, Tatemoto K, Polak JM, Bloom SR: Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology (1985) 89(3):494-499.
21. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR: Gut hormone PYY(3-36) physiologically inhibits food intake. Nature (2002) 418(6898):650-654.
22. Challis BG, Pinnock SB, Coll AP, Carter RN, Dickson SL, O'Rahilly S: Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem Biophs Res Commun (2003) 311(4):915-919.
23. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR: Inhibition of food intake in obese subjects by peptide YY3-36. New Engl J Med (2003) 349 10):941-948.
24. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP et al: A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 379(6560):69-72.
25. Dakin CL, Gunn I, Small CJ, Edwards CM, Hay DL, Smith DM, Ghatei MA, Bloom SR: Oxyntomodulin inhibits food intake in the rat. Endocrinology (2001) 142(10):4244-4250.
26. Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M, Ghatei MA, Bloom SR: Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinol (2004) 145(6):2687-2695.
27. Cohen MA, Ellis SM, Le Roux CW, Batterham RL, Park A, Patterson M, Frost GS, Ghatei MA, Bloom SR: Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab (2003) 88(10):4696-4701.
28. Baggio LL, Huang Q, Brown TJ, Drucker DJ: Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterol (2004) 127 2):546-548.
29. Kreymann B, Williams G, Ghatei MA, Bloom SR: Glucagon-like peptide-1, 7-36: A physiological incretin in man. Lancet (1987) 2(8571):1300-1304.
30. Todd JF, Wilding JP, Edwards CM, Khan FA, Ghatei MA, Bloom SR: Glucagon-like peptide (GLP-1): A trial of treatment in non-insulin dependent diabetes mellitus. Eur J Clin Invest (1997) 27 6):533-536.
31. Joy SV, Rodgers PT, Scates AC: Incretin mimetics as emerging treatments for type 2 diabetes. Ann Pharmacother (2005) 39(1):110-118.
32. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth hormone-releasing acylated peptide from stomach. Nature (1999) 402(6762):656-660.
33. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M: Ghrelin, a novel growth hormone-releasing acylated peptide is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinol (2000) 141(11):4255-4261.
34. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR: The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinol (2000) 141(11):4325-4328.
35. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes (2001) 50 8):1714-1719.
36. Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature (2000) 407(6806):908-913.
37. Cummings DE, Shannon MH: Ghrelin and gastric bypass: Is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab (2003) 88(7):2999-3002.
38. Lu S, Guan JL, Wang QP, Uehara K, Yamada S, Goto N, Date Y, Nakazato M, Kojima M, Kangawa K, Shioda S: Immunocytochemical observation of ghrelin containing neurons in the rat arcuate nucleus. Neurosci Lett (2002) 321(3):157-160.
39. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S: A role for ghrelin in the central regulation of feeding. Nature (2001) 409(6817):194-198.
40. Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M: The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology (2002) 123(4):1120-1128.
41. Lawrence CB, Snape AC, Baudoin FM, Luckman SM: Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology (2002) 143(1):155-162.
42. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, Heiman ML, Lehnert P, Fichter M, Tschop M: Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol (2001) 145(5):669-673.
43. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S: Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab (2002) 87(1):240-244.
44. Hansen TK, Dall R, Hosoda H, Kojima M, Kangawa K, Christiansen JS, Jorgensen JO: Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) (2002) 56(2):203-206.
45. English PJ, Ghatei MA, Malik IA, Bloom SR, Wilding JP: Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab (2002) 87(6):2984.
46. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature (1998) 395(6704):763-770.
47. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML: Circulating ghrelin levels are decreased in human obesity. Diabetes (2001) 50(4):707-709.
48. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ: Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med (2002) 346 21):1623-1630.
49. Naslund E, Gryback P, Hellstrom PM, Jacobsson H, Holst JJ, Theodorsson E, Backman L: Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord (1997) 21(5):387-392.
50. Le Roux CW: PYY and decreased appetite following jejunum intestinal bypass in rats. British Endocrine Societies Meeting, Glasgow, UK (2003) 22(5):Abs OC20.
51. Curran MP, Scott LJ. Orlistat: A review of its use in the management of patients with obesity. Drugs (2004) 64 24):2845-2864.
52. Finer N: Pharmacotherapy of obesity. Best Pract Res Clin Endocrinol Metab (2002) 16(4):717-742.
53. Finer N: Sibutramine: Its mode of action and efficacy. Int J Obes Relat Metab Disord (2002) 26(Suppl 4):S29-S33.